RIH Chiragenics defines and delivers advanced chemical and biochemical technologies and strategies and employs them in the design, discovery, delivery, and development of new drugs. Behind the company is an extensive web of synthetic chemistry patents and expertise covering processes and compositions that allow the preparation of very advanced small molecule drugs and new advanced materials for use in their delivery.
Process Capability : We specialize in chiral small ring and acyclic compounds with multiple chiral centers. Small ring systems such as tetrahydrofurans, pyrrolidines and cyclopentane derivatives are a special focus. Over 80% of our compounds are novel.
United States
